SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-026064
Filing Date
2021-05-13
Accepted
2021-05-13 16:06:00
Documents
3
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140813-8k_tffpharma.htm 8-K 26125
2 PRESS RELEASE DATED MAY 13, 2021 REGARDING THE REGISTRANT'S FINANCIAL RESULTS FO ea140813ex99-1_tffpharma.htm EX-99.1 83543
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9819
  Complete submission text file 0001213900-21-026064.txt   124432
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39102 | Film No.: 21919583
SIC: 2834 Pharmaceutical Preparations